Specialized Pro-Resolving Mediators
Products Related to Specialized Pro-Resolving Mediators(49)
- GC18552Lipoxin A4CAS: 89663-86-5Purity: >95.00%
Un acide gras trihydroxylé contenant un tétraène conjugué.
- GC18680Lipoxin A4 methyl esterCAS: 97643-35-1Purity: >95.00%
Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4.
- GC18681Lipoxin B4CAS: 98049-69-5Purity: >95.00%
Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes.
- GC26233Docosahexaenoic Acid-d5CAS: 1197205-71-2Purity: >99.00%
Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS.
- GC40609Lipoxin A5CAS: 110657-98-2Purity: >95.00%
Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.
- GC4097110(S),17(S)-DiHDHACAS: 871826-47-0Purity: >98.00%
La 10(S),17(S)-DiHDHA (également connue sous le nom de neuroprotectine D1 lorsqu'elle est produite dans les tissus neuronaux) est un acide gras dihydroxy dérivé du DHA qui présente de puissantes activités protectrices et anti-inflammatoires.
- GC4097517(S)-HpDHACAS: 123673-33-6Purity: >98.00%
17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.
- GC409787-epi Maresin 1CAS: 1268720-66-6Purity: >95.00%
7-epi Maresin 1 is the inactive 7(S) epimer of Maresin 1, which contains a 7(R) hydroxyl group.
- GC40981Protectin D1CAS: 660430-03-5Purity: >98.00%
La protectine D1, la neuroprotectine D1 lorsqu'elle est générée par des cellules neurales, fait partie d'une nouvelle famille de produits bioactifs générés À partir de l'acide docosahexaénoÏque.
- GC40982Resolvin D5CAS: 578008-43-2Purity: >95.00%
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.
- GC41169Lipoxin B4 methyl esterCAS: 97589-07-6Purity: >95.00%
Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4.
- GC4120614(S)-HDHACAS: 119433-37-3Purity: >98.00%
La 14(S)-HDHA (14(S)-HDoHE) est un produit d'oxygénation de l'acide docosahexaénoÏque (DHA).
- GC4120717(R)-HDHACAS: 155976-53-7Purity: >98.00%
Resolvins are a group of polyhydroxylated metabolites of docosahexaenoic acid (DHA) found in the inflammatory exudates of aspirin-treated experimental animals.
- GC4120817(S)-HDHACAS: 92693-03-3Purity: >98.00%
17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain.
- GC4122717(R)-Resolvin D1 methyl esterCAS: 937738-64-2Purity: >95.00%
17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM).
- GC41230Resolvin D1 methyl esterCAS: 937738-63-1Purity: >97.00%
L'ester méthylique de la résolvine D1 (ester méthylique RvD1) est l'ester méthylique de la résolvine D1.
- GC41231Resolvin D2 methyl esterCAS: 810668-53-2Purity: >95.00%
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase.
- GC41232Resolvin D3 methyl esterPurity: >95.00%
Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties.
- GC4141515(R)-Lipoxin A4CAS: 171030-11-8Purity: >95.00%
Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and function.
- GC414246(S)-Lipoxin A4CAS: 94292-80-5Purity: >95.00%
The lipoxins are trihydroxy fatty acids containing a 7,9,11,13-conjugated tetraene.
- GC4195117(R)-Resolvin D1CAS: 528583-91-7Purity: >95.00%
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.
- GC4195217(R)-Resolvin D4CAS: 528583-89-3Purity: >98.00%
17(R)-Resolvin D4 (17(R)-RvD4) is an aspirin-triggered epimer of RvD4 .
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC18552 | Lipoxin A4 | 89663-86-5 | >95.00% | |
Un acide gras trihydroxylé contenant un tétraène conjugué. | ||||
| GC18680 | Lipoxin A4 methyl ester | 97643-35-1 | >95.00% | |
Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. | ||||
| GC18681 | Lipoxin B4 | 98049-69-5 | >95.00% | |
Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes. | ||||
| GC26233 | Docosahexaenoic Acid-d5 | 1197205-71-2 | >99.00% | |
Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS. | ||||
| GC40609 | Lipoxin A5 | 110657-98-2 | >95.00% | |
Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes. | ||||
| GC40971 | 10(S),17(S)-DiHDHA | 871826-47-0 | >98.00% | |
La 10(S),17(S)-DiHDHA (également connue sous le nom de neuroprotectine D1 lorsqu'elle est produite dans les tissus neuronaux) est un acide gras dihydroxy dérivé du DHA qui présente de puissantes activités protectrices et anti-inflammatoires. | ||||
| GC40975 | 17(S)-HpDHA | 123673-33-6 | >98.00% | |
17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain. | ||||
| GC40978 | 7-epi Maresin 1 | 1268720-66-6 | >95.00% | |
7-epi Maresin 1 is the inactive 7(S) epimer of Maresin 1, which contains a 7(R) hydroxyl group. | ||||
| GC40980 | Maresin 2 | 1639809-46-3 | ≥95.00% | |
La marésine 2 est un médiateur anti-inflammatoire et pro-résolution des macrophages humains. | ||||
| GC40981 | Protectin D1 | 660430-03-5 | >98.00% | |
La protectine D1, la neuroprotectine D1 lorsqu'elle est générée par des cellules neurales, fait partie d'une nouvelle famille de produits bioactifs générés À partir de l'acide docosahexaénoÏque. | ||||
| GC40982 | Resolvin D5 | 578008-43-2 | >95.00% | |
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid. | ||||
| GC41169 | Lipoxin B4 methyl ester | 97589-07-6 | >95.00% | |
Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4. | ||||
| GC41206 | 14(S)-HDHA | 119433-37-3 | >98.00% | |
La 14(S)-HDHA (14(S)-HDoHE) est un produit d'oxygénation de l'acide docosahexaénoÏque (DHA). | ||||
| GC41207 | 17(R)-HDHA | 155976-53-7 | >98.00% | |
Resolvins are a group of polyhydroxylated metabolites of docosahexaenoic acid (DHA) found in the inflammatory exudates of aspirin-treated experimental animals. | ||||
| GC41208 | 17(S)-HDHA | 92693-03-3 | >98.00% | |
17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain. | ||||
| GC41227 | 17(R)-Resolvin D1 methyl ester | 937738-64-2 | >95.00% | |
17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM). | ||||
| GC41230 | Resolvin D1 methyl ester | 937738-63-1 | >97.00% | |
L'ester méthylique de la résolvine D1 (ester méthylique RvD1) est l'ester méthylique de la résolvine D1. | ||||
| GC41231 | Resolvin D2 methyl ester | 810668-53-2 | >95.00% | |
Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase. | ||||
| GC41232 | Resolvin D3 methyl ester | - | >95.00% | |
Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. | ||||
| GC41415 | 15(R)-Lipoxin A4 | 171030-11-8 | >95.00% | |
Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and function. | ||||
| GC41424 | 6(S)-Lipoxin A4 | 94292-80-5 | >95.00% | |
The lipoxins are trihydroxy fatty acids containing a 7,9,11,13-conjugated tetraene. | ||||
| GC41951 | 17(R)-Resolvin D1 | 528583-91-7 | >95.00% | |
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid. | ||||
| GC41952 | 17(R)-Resolvin D4 | 528583-89-3 | >98.00% | |
17(R)-Resolvin D4 (17(R)-RvD4) is an aspirin-triggered epimer of RvD4 . | ||||
| GC44138 | MCTR1 | 1784701-61-6 | ≥95% | |
Maresin conjugates in tissue regeneration 1 (MCTR1) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages at the site of inflammation. | ||||